|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2550 CAD | +2.00% |
|
+10.87% | - |
| 06-02 | Vext Science, Inc. Opens Sixth Dispensary in Fairfield Ohio | CI |
| 05-21 | Vext Science, Inc., Q1 2026 Earnings Call, May 21, 2026 |
Company Valuation: Vext Science, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 69.14 | 26.42 | 47.76 | 28.38 | 46.69 | 45.08 | - | - |
| Change | - | -61.79% | 80.79% | -40.58% | 64.53% | -3.44% | - | - |
| Enterprise Value (EV) 1 | 76.78 | 58.63 | 77.63 | 63.27 | 46.69 | 31.18 | 45.18 | 57.18 |
| Change | - | -23.63% | 32.4% | -18.51% | -26.21% | -33.21% | 44.9% | 26.56% |
| P/E | - | - | 7.07x | -1.43x | -2.66x | -18.2x | 18.2x | -18.2x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | 0x | 0.2x | 0.2x | -0x | 0x |
| Capitalization / Revenue | 1.86x | 0.75x | 1.37x | 0.79x | 0.91x | 0.84x | 0.65x | 0.61x |
| EV / Revenue | 2.06x | 1.66x | 2.23x | 1.76x | 0.91x | 0.58x | 0.66x | 0.77x |
| EV / EBITDA | 5.73x | 3.88x | 14x | 6.91x | - | 2x | 2.28x | 2.6x |
| EV / EBIT | - | - | -9.9x | -5.66x | - | 156x | 11x | - |
| EV / FCF | -10.8x | -20x | 46x | 34.7x | 5.73x | 3.31x | 2.55x | 2.91x |
| FCF Yield | -9.25% | -5.01% | 2.17% | 2.88% | 17.4% | 30.2% | 39.3% | 34.3% |
| Dividend per Share 3 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 3 | - | - | 0.041 | -0.115 | -0.0958 | -0.014 | 0.014 | -0.014 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 37.24 | 35.41 | 34.81 | 36 | 51.37 | 53.8 | 68.95 | 74 |
| EBITDA 1 | 13.39 | 15.12 | 5.528 | 9.153 | - | 15.6 | 19.8 | 22 |
| EBIT 1 | - | - | -7.843 | -11.18 | - | 0.2 | 4.1 | - |
| Net income 1 | - | - | - | - | -17.99 | -2.3 | 2.37 | -1.6 |
| Net Debt 1 | 7.635 | 32.22 | 29.88 | 34.89 | - | -13.9 | 0.1 | 12.1 |
| Reference price 3 | 0.6400 | 0.2400 | 0.2900 | 0.1650 | 0.2550 | 0.2550 | 0.2550 | 0.2550 |
| Nbr of stocks (in thousands) | 136,713 | 148,963 | 217,484 | 247,443 | 251,034 | 247,684 | - | - |
| Announcement Date | 20/04/22 | 22/03/23 | 10/05/24 | 31/03/25 | 29/04/26 | - | - | - |
1CAD in Million2USD in Million3CAD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -18.21x | 0.58x | 2x | - | 45.08M | |
| 13.74x | 1.12x | 5.61x | - | 225M | |
| 16x | - | - | - | 135M | |
| 9.62x | - | - | - | 126M | |
| -1.76x | 1.07x | 5.85x | - | 86.67M | |
| -1.07x | 0.64x | 2.81x | - | 85.25M | |
| Average | 3.05x | 0.85x | 4.07x | 117.19M | ||
| Weighted average by Cap. | 7.69x | 0.96x | 4.75x |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VEXT Stock
- Valuation Vext Science, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
